Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter

February 05, 2025

Healthy Returns: Why people quit weight loss, diabetes drugs within one year

February 04, 2025

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

January 31, 2025

FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use

January 28, 2025

World's largest luxury group LVMH posts better than feared full-year sales

January 28, 2025

Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses

January 28, 2025

Novo Nordisk shares pop 10% on early-stage weight loss drug trial results

January 24, 2025

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

January 21, 2025

'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says

January 21, 2025

GLP-1s and Brian Thompson’s killing loom large at top health-care conference

January 18, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

Eli Lilly CEO expects new weight loss pill to be approved next year

January 13, 2025

High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups

January 10, 2025

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says

January 08, 2025

Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk

January 07, 2025

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

December 24, 2024

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

December 24, 2024

CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?

December 22, 2024

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

December 20, 2024

Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results

December 20, 2024

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

December 18, 2024

Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch

December 18, 2024

Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition

December 17, 2024

Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing

December 11, 2024

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

December 11, 2024

The weight-loss drug boom has become one of the internet's biggest scams

December 08, 2024

Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data

December 05, 2024

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

December 05, 2024

Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds

December 04, 2024

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

December 04, 2024

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.